EW
Get informed when a big investor buys or sells
+ FollowFebruary 10, 2026 - AI Summary
Overvalued by 45% based on the discounted cash flow analysis.
| Market cap | $49.79 Billion |
|---|---|
| Enterprise Value | $48.09 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $1.84 |
| Beta | 0.87 |
| Outstanding Shares | 579,200,000 |
| P/E Ratio | 45.83 |
|---|---|
| PEG | 722.79 |
| Price to Sales | 8.6 |
| Price to Book Ratio | 5.06 |
| Enterprise Value to Revenue | 7.63 |
| Enterprise Value to EBIT | 36.65 |
| Enterprise Value to Net Income | 43 |
| Total Debt to Enterprise | 0.01 |
| Debt to Equity | 0.07 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 1.5154▲ 18.28% |
|---|---|
| Total Calls | 1,543,982▼ 49.50% |
| Total Puts | 2,339,797▼ 42.58% |
Holdings and activity of institutional investors.
| Ownership % | 86.11%▼ 0.27% |
|---|---|
| Total Invested | $40.32B▼ 6.37% |
| Investors Holding | 1,330▼ 33.00% |
No data
This powerful committee controls taxation, trade, and entitlement spending, including Medicare and Medicaid. Its decisions on tax policy and healthcare reimbursement rates (e.g., for heart valves and surgical instruments) directly impact Edwards Lifesciences' profitability and market access.
This committee allocates discretionary federal spending. Its subcommittees determine the precise funding for various healthcare programs (e.g., Medicare, NIH research, VA hospitals), directly impacting the demand for and reimbursement of Edwards Lifesciences' medical devices.
This is a primary committee for the medical device industry, as it regulates the FDA (Food and Drug Administration) and NIH (National Institutes of Health). FDA oversight is central to product approval, manufacturing, and marketing for Edwards Lifesciences.
This committee oversees antitrust laws and intellectual property. Intellectual property protection (patents) is critical for medical device innovation and competitiveness, making this committee highly relevant to Edwards Lifesciences' core assets.
This committee directly oversees the Department of Veterans Affairs. Its funding and policy decisions directly impact government healthcare contractors and medical device manufacturers like Edwards Lifesciences, especially if they supply VA hospitals and clinics.